Oern Stuge

3 results

Manus Rogan of Fountain Healthcare and Peter Crosby, chief executive of Mainstay Medical.

Back pain group Mainstay Medical has floated in Paris and Dublin in an IPO that values the early stage medical device company (...)

Trials are starting initially in Australia as the regulatory path there was considered quicker to negotiate, according to the company’s Australian chief executive, Peter Crosby.

It has taken three years to get a product to trials: Mainstay Medical hopes that within another two, it will have a device on the market in Eur(...)

“The results are, for us at least, pretty exciting. They show that the therapy that’s delivered by our product appears to work and the results have certainly captured the attention of the clinical community with which we work,” said Mainstay chief executive Peter Crosby.

Mainstay Medical, an Irish medtech company targeting chronic lower back pain, is starting clinical trials on its Reactiv8 implantable device. (...)